E. KIRCALİ Et Al. , "Impact of Peritransplant Metronidazole Use on Acute Graft Versus Host Disease in Allogeneic Hematopoietic Transplant Patients," Transplantation and Cellular Therapy Meetings of ASTCT and CIBMTR , 2021
KIRCALİ, E. Et Al. 2021. Impact of Peritransplant Metronidazole Use on Acute Graft Versus Host Disease in Allogeneic Hematopoietic Transplant Patients. Transplantation and Cellular Therapy Meetings of ASTCT and CIBMTR .
KIRCALİ, E., SEVAL, G. C., ÖZTÜRK, C., BOZDAĞ, S., YÜKSEL, M. K., TOPÇUOĞLU, P., ... ARSLAN, Ö.(2021). Impact of Peritransplant Metronidazole Use on Acute Graft Versus Host Disease in Allogeneic Hematopoietic Transplant Patients . Transplantation and Cellular Therapy Meetings of ASTCT and CIBMTR
KIRCALİ, EKİN Et Al. "Impact of Peritransplant Metronidazole Use on Acute Graft Versus Host Disease in Allogeneic Hematopoietic Transplant Patients," Transplantation and Cellular Therapy Meetings of ASTCT and CIBMTR, 2021
KIRCALİ, EKİN Et Al. "Impact of Peritransplant Metronidazole Use on Acute Graft Versus Host Disease in Allogeneic Hematopoietic Transplant Patients." Transplantation and Cellular Therapy Meetings of ASTCT and CIBMTR , 2021
KIRCALİ, E. Et Al. (2021) . "Impact of Peritransplant Metronidazole Use on Acute Graft Versus Host Disease in Allogeneic Hematopoietic Transplant Patients." Transplantation and Cellular Therapy Meetings of ASTCT and CIBMTR .
@conferencepaper{conferencepaper, author={EKİN KIRCALİ Et Al. }, title={Impact of Peritransplant Metronidazole Use on Acute Graft Versus Host Disease in Allogeneic Hematopoietic Transplant Patients}, congress name={Transplantation and Cellular Therapy Meetings of ASTCT and CIBMTR}, city={}, country={}, year={2021}}